Avoro Capital Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.18 Billion
- Q1 2025
A detailed history of Avoro Capital Advisors LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,022,222 shares of MDGL stock, worth $669 Million. This represents 10.84% of its overall portfolio holdings.
Number of Shares
2,022,222
Previous 2,029,000
0.33%
Holding current value
$669 Million
Previous $626 Million
6.98%
% of portfolio
10.84%
Previous 9.12%
Shares
20 transactions
Others Institutions Holding MDGL
# of Institutions
364Shares Held
23.2MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$730 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$695 Million39.89% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$660 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$653 Million7.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$559 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.66B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...